Ship traffic connects Antarctica's fragile coasts to worldwide ecosystems.

Antarctica, an isolated and long considered pristine wilderness, is becoming increasingly exposed to the negative effects of ship-borne human activity, and especially the introduction of invasive species. Here, we provide a comprehensive quantitative analysis of ship movements into Antarctic waters and a spatially explicit assessment of introduction risk for nonnative marine species in all Antarctic waters. We show that vessels traverse Antarctica's isolating natural barriers, connecting it directly via an extensive network of ship activity to all global regions, especially South Atlantic and European ports. Ship visits are more than seven times higher to the Antarctic Peninsula (especially east of Anvers Island) and the South Shetland Islands than elsewhere around Antarctica, together accounting for 88% of visits to Southern Ocean ecoregions. Contrary to expectations, we show that while the five recognized "Antarctic Gateway cities" are important last ports of call, especially for research and tourism vessels, an additional 53 ports had vessels directly departing to Antarctica from 2014 to 2018. We identify ports outside Antarctica where biosecurity interventions could be most effectively implemented and the most vulnerable Antarctic locations where monitoring programs for high-risk invaders should be established.

Antarctica: The final frontier for marine biological invasions.

Antarctica is experiencing significant ecological and environmental change, which may facilitate the establishment of non-native marine species. Non-native marine species will interact with other anthropogenic stressors affecting Antarctic ecosystems, such as climate change (warming, ocean acidification) and pollution, with irreversible ramifications for biodiversity and ecosystem services. We review current knowledge of non-native marine species in the Antarctic region, the physical and physiological factors that resist establishment of non-native marine species, changes to resistance under climate change, the role of legislation in limiting marine introductions, and the effect of increasing human activity on vectors and pathways of introduction. Evidence of non-native marine species is limited: just four marine non-native and one cryptogenic species that were likely introduced anthropogenically have been reported freely living in Antarctic or sub-Antarctic waters, but no established populations have been reported; an additional six species have been observed in pathways to Antarctica that are potentially at risk of becoming invasive. We present estimates of the intensity of ship activity across fishing, tourism and research sectors: there may be approximately 180 vessels and 500+ voyages in Antarctic waters annually. However, these estimates are necessarily speculative because relevant data are scarce. To facilitate well-informed policy and management, we make recommendations for future research into the likelihood of marine biological invasions in the Antarctic region.

Identifying marine invasion threats and management priorities through introduction pathway analysis in a remote sub-Antarctic ecosystem.

The threat from novel marine species introductions is a global issue. When non-native marine species are introduced to novel environments and become invasive, they can affect biodiversity, industry, ecosystem function, and both human and wildlife health. Isolated areas with sensitive or highly specialised endemic species can be particularly impacted. The global increase in the scope of tourism and other human activities, together with a rapidly changing climate, now put these remote ecosystems under threat. In this context, we analyse invasion pathways into South Georgia and the South Sandwich Islands (SGSSI) for marine non-native species via vessel biofouling. The SGSSI archipelago has high biodiversity and endemism, and has historically been highly isolated from the South American mainland. The islands sit just below the Polar Front temperature boundary, affording some protection against introductions. However, the region is now warming and SGSSI increasingly acts as a gateway port for vessel traffic into the wider Antarctic, amplifying invasion likelihood. We use remote Automatic Identification System vessel-tracking data over a 2-year period to map vessel movement and behaviour around South Georgia, and across the 'Scotia Sea', 'Magellanic' and northern 'Continental High Antarctic' ecoregions. We find multiple vessel types from locations across the globe frequently now enter shallow inshore waters and stop for prolonged periods (weeks/months) at anchor. Vessels are active throughout the year and stop at multiple port hubs, frequently crossing international waters and ecoregions. Management recommendations to reduce marine invasion likelihood within SGSSI include initiating benthic and hull monitoring at the identified activity/dispersion hubs of King Edward Point, Bay of Isles, Gold Harbour, St Andrews Bay and Stromness Bay. More broadly, regional collaboration and coordination is necessary at neighbouring international ports. Here vessels need increased pre- and post-arrival biosecurity assessment following set protocols, and improved monitoring of hulls for biofouling to pre-emptively mitigate this threat.

Continental drift? Do European clinical genetic testing laboratories have a patent problem?

Recent US Supreme Court decisions have invalidated patent claims on isolated genomic DNA, and testing methods that applied medical correlations using conventional techniques. As a consequence, US genetic testing laboratories have a relatively low risk of infringing patents on naturally occurring DNA or methods for detecting genomic variants. In Europe, however, such claims remain patentable, and European laboratories risk infringing them. We report the results from a survey that collected data on the impact of patents on European genetic testing laboratories. The results indicate that the proportion of European laboratories that have refrained from providing associated testing services owing to patent protection has increased over the last decade (up from 7% in 2008 to 15% in 2017), and that the non-profit sector was particularly strongly affected (up from 4% in 2008 to 14% in 2017). We renew calls for more readily available legal support to help public sector laboratories deal with patent issues, but we do not recommend aligning European law with US law at present. Watchful monitoring is also recommended to ensure that patents do not become a greater hindrance for clinical genetic testing laboratories.